Harvard Bioscience Inc (HBIO)
2.26
-0.03
(-1.31%)
USD |
NASDAQ |
Nov 15, 09:54
Harvard Bioscience Free Cash Flow: 0.16M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.16M |
| June 30, 2024 | 6.073M |
| March 31, 2024 | 10.81M |
| December 31, 2023 | 11.72M |
| September 30, 2023 | 10.92M |
| June 30, 2023 | 7.166M |
| March 31, 2023 | 3.607M |
| December 31, 2022 | -0.438M |
| September 30, 2022 | -3.123M |
| June 30, 2022 | -4.47M |
| March 31, 2022 | -3.276M |
| December 31, 2021 | -0.083M |
| September 30, 2021 | 2.334M |
| June 30, 2021 | 4.507M |
| March 31, 2021 | 6.035M |
| December 31, 2020 | 7.929M |
| September 30, 2020 | 7.535M |
| June 30, 2020 | 9.305M |
| March 31, 2020 | 7.592M |
| December 31, 2019 | 6.829M |
| September 30, 2019 | 7.569M |
| June 30, 2019 | 3.075M |
| March 31, 2019 | 3.823M |
| December 31, 2018 | 1.898M |
| September 30, 2018 | -1.776M |
| Date | Value |
|---|---|
| June 30, 2018 | 1.806M |
| March 31, 2018 | 0.908M |
| December 31, 2017 | 0.128M |
| September 30, 2017 | 2.482M |
| June 30, 2017 | 3.489M |
| March 31, 2017 | 3.997M |
| December 31, 2016 | 3.904M |
| September 30, 2016 | 3.786M |
| June 30, 2016 | 0.152M |
| March 31, 2016 | -1.663M |
| December 31, 2015 | -2.273M |
| September 30, 2015 | -2.875M |
| June 30, 2015 | -2.017M |
| March 31, 2015 | 0.015M |
| December 31, 2014 | 2.346M |
| September 30, 2014 | 2.58M |
| June 30, 2014 | 3.385M |
| March 31, 2014 | 2.949M |
| December 31, 2013 | 2.381M |
| September 30, 2013 | 2.391M |
| June 30, 2013 | 3.426M |
| March 31, 2013 | 5.145M |
| December 31, 2012 | 6.231M |
| September 30, 2012 | 7.542M |
| June 30, 2012 | 6.504M |
Free Cash Flow Range, Past 5 Years
-4.47M
Minimum
Jun 2022
11.72M
Maximum
Dec 2023
4.556M
Average
6.054M
Median
Free Cash Flow Benchmarks
| Bruker Corp | 156.70M |
| Azenta Inc | 40.93M |
| Bionano Genomics Inc | -106.10M |
| Akoya Biosciences Inc | -53.61M |
| Singular Genomics Systems Inc | -77.98M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.842M |
| Cash from Investing (Quarterly) | -1.111M |
| Cash from Financing (Quarterly) | 2.104M |
| Free Cash Flow Per Share (Quarterly) | -0.0448 |
| Free Cash Flow to Equity (Quarterly) | -4.131M |
| Free Cash Flow to Firm (Quarterly) | -1.038M |
| Free Cash Flow Yield | 0.16% |